Rev1 Ventures is the famous VC, which was founded in 2005. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Columbus.
Opposing the other organizations, this Rev1 Ventures works on 23 percentage points less the average amount of lead investments. When the investment is from Rev1 Ventures the average startup value is 5-10 millions dollars. The fund is generally included in 7-12 deals every year. The high activity for fund was in 2017. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2018. The usual things for fund are deals in the range of 1 - 5 millions dollars. Considering the real fund results, this VC is 6 percentage points more often commits exit comparing to other organizations.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Rev1 Ventures, startups are often financed by NCT Ventures, Charter Life Sciences, 10Xelerator. The meaningful sponsors for the fund in investment in the same round are NCT Ventures, JumpStart Inc., Tamarind Hill. In the next rounds fund is usually obtained by JumpStart Inc., Tamarind Hill, PointGuard Ventures.
Besides them, we counted 10 critical employees of this fund in our database.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Information Technology, Enterprise Software. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the various public portfolio startups of the fund, we may underline Unific, Seen Digital Media, Inc., ClearSaleing
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Myoptechs | $2M | 04 Sep 2024 | Columbus, Ohio, United States | ||
Power to Hydrogen | $18M | 19 Aug 2024 | Columbus, Ohio, United States | ||
Niobium Microsystems | $5M | 07 May 2024 | Dayton, Ohio, United States | ||
Trace 3D | $2M | 24 Apr 2024 | - | ||
CHAMPtitles | $18M | 27 Mar 2024 | Cleveland, Ohio, United States | ||
Redi.Health | $14M | 28 Feb 2024 | Columbus, Ohio, United States | ||
Basking Biosciences | $55M | 30 Jan 2024 | Durham, North Carolina, United States | ||
Clarametyx Biosciences | $33M | 05 Jan 2024 | Columbus, Ohio, United States | ||
Invirsa | $7M | 14 Jun 2023 | Columbus, Ohio, United States |
– Eikonoklastes Therapeutics from Cincinnati, Ohio develops immunotherapies to treat a broad range of cancers beginning with Triple Negative Breast Cancer (TNBC), a lethal form of breast cancer that comprises 15% of all breast cancers.
– The company raised an undisclosed amount in Series A funding.
– The round was led by CincyTech with participation from New York-based Elk Capital Ventures, Jobs Ohio, Rev1, and other undisclosed investors.
– The new investment will be used to conduct Investigational New Drug (IND) enabling studies for Eikonoklastes Therapeutics’ L-ICON3 immune conjugate platform.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Myoptechs | $2M | 04 Sep 2024 | Columbus, Ohio, United States | ||
Power to Hydrogen | $18M | 19 Aug 2024 | Columbus, Ohio, United States | ||
Niobium Microsystems | $5M | 07 May 2024 | Dayton, Ohio, United States | ||
Trace 3D | $2M | 24 Apr 2024 | - | ||
CHAMPtitles | $18M | 27 Mar 2024 | Cleveland, Ohio, United States | ||
Redi.Health | $14M | 28 Feb 2024 | Columbus, Ohio, United States | ||
Basking Biosciences | $55M | 30 Jan 2024 | Durham, North Carolina, United States | ||
Clarametyx Biosciences | $33M | 05 Jan 2024 | Columbus, Ohio, United States | ||
Invirsa | $7M | 14 Jun 2023 | Columbus, Ohio, United States |